ArticleCureus2025
Management of Glycogen-Rich Clear Cell Carcinoma of the Breast: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycogen-Rich Clear Cell Carcinoma of the Breast: Report of Two New Cases and an Updated Literature Review.Acta medica academica · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report presents an asymptomatic 75-year-old female with a screening mammogram revealing a left-sided breast lesion, ultimately diagnosed as glycogen-rich clear cell carcinoma (GRCC) following a comprehensive evaluation and histopathological confirmation. Initial ultrasound-guided biopsy suggested a papillary neoplasm, which was discordant, and was followed by a magnetic resonance imaging (MRI)-guided biopsy showing fibrocystic changes throughout and a complex sclerosing lesion with flat epithelial atypia. We proceeded with a lumpectomy without a sentinel lymph node biopsy. Final pathology revealed findings consistent with GRCC. A multidisciplinary discussion recommended forgoing axillary surgery and proceeding with radiation, hormonal therapy, and chemotherapy. This case highlights the challenges of diagnosing rare cancers, such as GRCC, and the importance of excisional biopsy in the diagnostic process. We also emphasize the importance of multidisciplinary tumor board discussions regarding rare lesions, such as GRCC, to help guide disease management and follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.